BioMagnetic Solutions

BioMagnetic Solutions

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

BioMagnetic Solutions is a private, revenue-generating medical device and diagnostics company specializing in ferrofluid-based cell selection technologies. Founded in 2010 and headquartered in San Diego, it targets the rapidly growing cell and gene therapy manufacturing market with cGMP-compliant products. The company is a strategic asset within the Gamma Biosciences platform, leveraging partnerships with industry leaders like Lonza to integrate its reagents into automated manufacturing systems, positioning it as a key tools provider in the advanced therapies space.

DiagnosticsMedical Devices

Technology Platform

cGMP-grade ferrofluid-based magnetic cell selection technology for isolating specific cell populations, comprising functionalized reagents and compatible hardware systems.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The rapid growth of the cell and gene therapy market creates massive demand for robust, scalable manufacturing tools.
Strategic partnerships with automated platform manufacturers like Lonza provide direct access to large customer bases and can create locked-in reagent revenue streams.

Risk Factors

Faces intense competition from large, established life science tools companies.
Success is dependent on the adoption of its specific ferrofluid technology and the broader pace of cell therapy commercialization.
Heavy reliance on its parent company for strategy and funding.

Competitive Landscape

The cell separation market is dominated by large players like Miltenyi Biotec, STEMCELL Technologies, and Thermo Fisher Scientific. BioMagnetic Solutions competes by focusing on cGMP-grade ferrofluid performance for the clinical manufacturing niche and through strategic integrations with automated platforms, rather than competing across the entire research tools landscape.